# Α Prospective Observational Study for the Evaluation of Disease Control and Quality of Life in Patients With Benign PROStatic hyPERplasia Under Fixed Dose combΙnaTion Treatment With Dutasteride and Tamsulosin . PROSPERITY Group of Studies (I&II)

> **NCT04831476** · — · COMPLETED · sponsor: **Elpen Pharmaceutical Co. Inc.** · enrollment: 1296 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

- **OTHER:** Patients with Benign Prostate Hyperplasia

## Key facts

- **NCT ID:** NCT04831476
- **Lead sponsor:** Elpen Pharmaceutical Co. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2022-10-31
- **Final completion:** 2022-10-31
- **Target enrollment:** 1296 (ACTUAL)
- **Last updated:** 2023-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04831476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04831476, "Α Prospective Observational Study for the Evaluation of Disease Control and Quality of Life in Patients With Benign PROStatic hyPERplasia Under Fixed Dose combΙnaTion Treatment With Dutasteride and Tamsulosin . PROSPERITY Group of Studies (I&II)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04831476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*